These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4074612)

  • 1. The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum.
    Kerr DJ; Graham J; Blackie RG; McGovern E; Kelman AW; Cunningham D; Kaye SB
    Br J Clin Pharmacol; 1985 Oct; 20(4):426-7. PubMed ID: 4074612
    [No Abstract]   [Full Text] [Related]  

  • 2. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.
    McDermed JE; Cohen JL; Joseph C; Strum SB
    J Clin Oncol; 1985 Oct; 3(10):1400-8. PubMed ID: 3900303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of cisplatin induced emesis--a multidisciplinary intervention strategy.
    Fürst CJ; Johansson S; Fredrikson M; Hursti T; Steineck G; Peterson C
    Med Oncol Tumor Pharmacother; 1992; 9(2):81-6. PubMed ID: 1341720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
    Roila F
    Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal control of acute cisplatin-induced emesis.
    Verweij J; de Wit R; de Mulder PH
    Oncology; 1996 Jun; 53 Suppl 1():56-64. PubMed ID: 8692553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
    Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
    J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D; Briemann L; Hellstern A; Hess H; Mitrou P; Hodgson M; Achtert G; Brockmann P; Hausleiter HJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):43-7. PubMed ID: 4038385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
    Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
    Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.
    Marty M; Pouillart P; Scholl S; Droz JP; Azab M; Brion N; Pujade-Lauraine E; Paule B; Paes D; Bons J
    N Engl J Med; 1990 Mar; 322(12):816-21. PubMed ID: 2137902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and delayed emesis after cisplatin-based regimen: description and prevention.
    Louvet C; Lorange A; Letendre F; Beaulieu R; Pretty HM; Courchesne Y; Neemeh JA; Monte M; Latreille J
    Oncology; 1991; 48(5):392-6. PubMed ID: 1745487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic analysis of ondansetron versus metoclopramide for cisplatin-induced nausea and vomiting.
    Zbrozek AS; Cantor SB; Cardenas MP; Hill DP
    Am J Hosp Pharm; 1994 Jun; 51(12):1555-63. PubMed ID: 8092156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective control of cisplatin induced emesis by combination drug regimen.
    Misra R; Agarwal N
    Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism following i.v. administration of high-dose metoclopramide used as an antiemetic agent during cancer chemotherapy.
    Markman M; Newman DR; Hawkins RS
    Cancer Treat Rep; 1985 Mar; 69(3):341-2. PubMed ID: 4038919
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
    Senn HJ; Glaus A; Bachmann-Mettler I
    J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on the control of cisplatin-induced emesis in dogs].
    Ito J; Okada M; Abo T; Okamoto Y; Yamashita T; Takahashi K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):706-10. PubMed ID: 3827261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.